(Q81311015)
Statements
Randomized phase II trial of cetuximab, bevacizumab, and irinotecan compared with cetuximab and bevacizumab alone in irinotecan-refractory colorectal cancer: the BOND-2 study (English)
Hedy L Kindler
Howard S Hochster
Scott Wadler
Paulo M Hoff
Nancy E Kemeny
Ellen M Hollywood
Mithat Gonen
Marcus Quinones
Meroe Morse
17 September 2007